Skip to main content
logo
Radiopharm Theranostics Limited (ASX:RAD)
Australia flag Australia · Delayed Price · Currency is AUD
0.0090
0.00 (0.00%)
Sep 11, 2026, 9:59 AM AEST

Radiopharm Theranostics Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
396752173638
Market Cap Growth
-43.08%29.43%197.41%-50.90%-7.01%-
Enterprise Value
33311416136
Last Close Price
0.010.020.020.040.100.14

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
2.894.994.168.935.74-
PB Ratio
1.753.021.210.640.780.61
P/TBV Ratio
-----5.56

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
2.412.301.158.022.04-

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Debt / Equity Ratio
-0.18-0.18-0.68-0.68-0.26-0.43
Net Debt / EBITDA Ratio
0.080.080.900.580.461.59
Net Debt / FCF Ratio
0.080.080.800.810.502.72
Asset Turnover
0.180.180.160.030.08-
Quick Ratio
1.141.142.651.111.223.43
Current Ratio
1.161.162.671.301.233.46
Return on Equity (ROE)
-174.71%-174.71%-109.20%-131.49%-63.78%-96.82%
Return on Assets (ROA)
-44.61%-44.61%-27.70%-30.04%-22.57%-29.86%
Return on Capital Employed (ROCE)
-126.90%-126.90%-49.10%-64.90%-46.30%-26.40%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-141.27%-81.90%-73.69%-274.09%-97.15%-79.40%
FCF Yield
-135.21%-78.38%-70.43%-131.34%-65.25%-25.86%
Buyback Yield / Dilution
-48.05%-48.05%-438.49%-26.36%-68.74%-